eEF2K—a new target in breast cancers with combined inactivation of p53 and PTEN
Abstract Extensive efforts have now characterized the somatic molecular alterations in human breast cancer (Cancer Genome Atlas Network, 2012; Stephens et al, 2012) and have led to a re‐definition of the disease as a constellation of 10 distinct driver‐based subtypes (IntClust subtypes) (Curtis et a...
Saved in:
| Main Authors: | Hege G Russnes, Carlos Caldas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2014-12-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.201404683 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined deletion of Pten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on eEF2K
by: Jeff C Liu, et al.
Published: (2014-10-01) -
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
by: Jianxun Song, et al.
Published: (2022-03-01) -
eEF2K as an important kinase associated with cancer survival and prognosis
by: Nan Wang, et al.
Published: (2024-11-01) -
Licochalcone A suppresses pancreatic ductal adenocarcinoma progression by targeting eEF2K-mediated pyroptosis
by: Junjie Peng, et al.
Published: (2025-06-01) -
Multidimensional Regulatory Mechanisms and Targeting Strategies of the eEF1 Family in RNA Virus Infection
by: Xin Wang, et al.
Published: (2025-05-01)